Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Jimenez-Sousa, MA; Gomez-Moreno, AZ; Pineda-Tenor, D; Medrano, LM; Sanchez-Ruano, JJ; Fernandez-Rodriguez, A; Artaza-Varasa, T; Saura-Montalban, J; Vazquez-Moron, S; Ryan, P; Resino, S.

The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design

PLoS One. 2018; 13(5): Nº de citas: 7 [doi:10.1371/journal.pone.0197115]

Perez-Latorre, L; Sanchez-Conde, M; Miralles, P; Lopez, JC; Parras, F; Tejerina, F; Aldamiz-Echevarria, T; Carrero, A; Diez, C; Ramirez, M; Gutierrez, I; Bellon, JM; Banares, R; Berenguer, J.

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis

BMC INFECTIOUS DISEASES. 2018; 18: 170-170 Nº de citas: 1 [doi:10.1186/s12879-018-3067-z]

Gonzalez-Baeza, A; Dolengevich-Segal, H; Perez-Valero, I; Cabello, A; Tellez, MJ; Sanz, J; Perez-Latorre, L; Bernardino, JI; Troya, J; De La Fuente, S; Bisbal, O; Santos, I; Arponen, S; Hontanon, V; Casado, JL; Ryan, P; U-SEX GESIDA 9416 Study.

Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study

AIDS PATIENT CARE AND STDS. 2018; 32(3): 112-118 Nº de citas: 99 [doi:10.1089/apc.2017.0263]

Alvaro-Meca, A; Ryan, P; Martinez-Larrull, E; Micheloud, D; Berenguer, J; Resino, S.

Epidemiological trends of deep venous thrombosis in HIV-infected subjects (1997-2013): A nationwide population-based study in Spain

EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2018; 48: 69-74 Nº de citas: 4 [doi:10.1016/j.ejim.2017.10.012]

Merchante, N; Aldamiz-Echevarria, T; Garcia-Alvarez, M; Rivero-Juarez, A; Macias, J; Miralles, P; Jimenez-Sousa, MA; Mancebo, M; Perez-Latorre, L; Pineda-Tenor, D; Berenguer, J; Resino, S; Pineda, JA.

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients

JOURNAL OF VIRAL HEPATITIS. 2018; 25(2): 180-186 Nº de citas: 4 [doi:10.1111/jvh.12769]

Berenguer, J; Jarrin, I; Perez-Latorre, L; Hontanon, V; Vivancos, MJ; Navarro, J; Tellez, MJ; Guardiola, JM; Iribarren, JA; Rivero-Juarez, A; Marquez, M; Artero, A; Morano, L; Santos, I; Moreno, J; Farinas, MC; Galindo, MJ; Hernando, MA; Montero, M; Cifuentes, C; Domingo, P; Sanz, J; Domingez, L; Ferrero, OL; De la Fuente, B; Rodriguez, C; Reus, S; Hernandez-Quero, J; Gaspar, G; Perez-Martinez, L; Garcia, C; Force, L; Veloso, S; Losa, JE; Vilaro, J; Bernal, E; Arponen, S; Orti, AJ; Chocarro, A; Teira, R; Alonso, G; Silvarino, R; Vegas, A; Geijo, P; Bisbe, J; Esteban, H; Gonzalez-Garcia, J.

Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant

Open Forum Infectious Diseases. 2018; 5(1): Nº de citas: 20 [doi:10.1093/ofid/ofx258]

Garcia, M; Gorgolas, M; Cabello, A; Estrada, V; Ligos, JM; Fernandez-Guerrero, M; Barros, C; Lopez-Bernaldo, JC; De la Hera, FJ; Montoya, M; Benito, JM; Rallon, N.

Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART

Scientific Reports. 2017; 7: Nº de citas: 22 [doi:10.1038/s41598-017-17057-y]

Guardo, AC; Gomez, CE; Diaz-Brito, V; Pich, J; Arnaiz, JA; Perdiguero, B; Garcia-Arriaza, J; Gonzalez, N; Sorzano, COS; Jimenez, L; Jimenez, JL; Munoz-Fernandez, MA; Gatell, JM; Alcam, J; Esteban, M; de Quiros, JCLB; Garcia, F; Plana, M; RISVAC02boost Study.

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

PLoS One. 2017; 12(10): Nº de citas: 16 [doi:10.1371/journal.pone.0186602]

Medrano, LM; Berenguer, J; Jimenez-Sousa, MA; Aldamiz-Echevarria, T; Tejerina, F; Diez, C; Vigon, L; Fernandez-Rodriguez, A; Resino, S.

ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients

Scientific Reports. 2017; 7: Nº de citas: 8 [doi:10.1038/s41598-017-12885-4]

Guillen, SM; Garcia, JEL; Berenguer, JB; Sesmero, JMM; Gomis, SC; Graefehain, R; Sanchez-Cambronero, DL; Garcia, FJP.

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV plus patients in Spain

FARMACIA HOSPITALARIA. 2017; 41(5): 601-610

Berenguer, J; Rodriguez-Castellano, E; Carrero, A; Von Wichmann, MA; Montero, M; Galindo, MJ; Mallolas, J; Crespo, M; Ellez, MJT; Quereda, C; Sanz, J; Barros, C; Tural, C; Santos, I; Pulido, F; Guardiola, JM; Rubio, R; Ortega, E; Montes, ML; Jusdado, JJ; Gaspar, G; Esteban, H; Bellon, JEM; Gonzalez-Garcia, J.

Eradication of Hepatitis C Virus and Non-Liver-Related Non-Acquired Immune Deficiency Syndrome-Related Events in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

HEPATOLOGY. 2017; 66(2): 344-356 Nº de citas: 49 [doi:10.1002/hep.29071]

Alvaro-Meca, A; Berenguer, J; Diaz, A; Micheloud, D; Aldamiz-Echevarria, T; Fanciulli, C; Resino, S.

Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era

PLoS One. 2017; 12(6): Nº de citas: 12 [doi:10.1371/journal.pone.0179493]

Moreno, S; Antela, A; Garcia, F; del Amo, J; Boix, V; Coll, P; Fortuny, C; Sirvent, JLG; Gutierrez, F; Iribarren, JA; Llibre, JM; de Quiros, JCLB; Losa, JE; Lozano, A; Meulbroek, M; Olalla, J; Pujol, F; Pulido, F; Casal, MC; Garcia, JG; Aldeguer, JL; Molina, JAP; Palter, DP; Roman, AR; Grp Redactor GESIDA SEIMC.

Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2017; 35(6): 377-383 Nº de citas: 8 [doi:10.1016/j.eimc.2016.11.016]

Rosado-Sanchez, I; Jarrin, I; Pozo-Balado, MM; de Pablo-Bernal, RS; Herrero-Fernandez, I; Alvarez-Rios, AI; Rodriguez-Gallego, E; Genebat, M; Vera, M; Berenguer, J; Martin, ML; Bernal, E; Vidal, F; Blanco, J; Leal, M; Pacheco, YM.

Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recovery

ANTIVIRAL RESEARCH. 2017; 142: 76-82 Nº de citas: 19 [doi:10.1016/j.antiviral.2017.03.015]

Montes, ML; Olveira, A; Ahumada, A; Aldamiz, T; Garcia-Samaniego, J; Clemente, A; Berenguer, J; Gonzalez-Garcia, J; Martin-Carbonero, L.

Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection

AIDS. 2017; 31(9): 1253-1260 Nº de citas: 36 [doi:10.1097/QAD.0000000000001465]

Branas, F; Jimenez, Z; Sanchez-Conde, M; Dronda, F; De Quiros, JCLB; Perez-Elias, MJ; Miralles, P; Ramirez, M; Moreno, A; Berenguer, J; Moreno, S.

Frailty and physical function in older HIV-infected adults

AGE AND AGEING. 2017; 46(3): 522-526 Nº de citas: 55 [doi:10.1093/ageing/afx013]

Perez-Lago, L; Herranz, M; Navarro, Y; Serrano, MJR; Miralles, P; Bouza, E; Garcia-De-Viedma, D.

Clonal Complexity in Mycobacterium tuberculosis Can Hamper Diagnostic Procedures

JOURNAL OF CLINICAL MICROBIOLOGY. 2017; 55(5): 1388-1395 Nº de citas: 2 [doi:10.1128/JCM.00149-17]

Sulkowski, MS; Fessel, WJ; Lazzarin, A; Berenguer, J; Zakharova, N; Cheinquer, H; Cote, P; Dieterich, D; Gadano, A; Matthews, G; Molina, JM; Moreno, C; Pineda, JA; Pulido, F; Rivero, A; Rockstroh, J; Hernandez, D; McPhee, F; Eley, T; Liu, ZH; Mendez, P; Hughes, E; Noviello, S; Ackerman, P.

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

HEPATOLOGY INTERNATIONAL. 2017; 11(2): 188-198 Nº de citas: 2 [doi:10.1007/s12072-017-9788-z]